"More than 70% of women experience joint discomfort during menopause, a phenomenon now recognized as the ‘musculoskeletal syndrome of menopause.’ Emerging research highlights how lifestyle choices and targeted supplementation can offer significant support to cartilage health and joint function through this life stage."
The menopausal transition, a significant biological shift typically occurring between the ages of 45 and 55, brings about a cascade of hormonal changes, most notably a decline in estrogen levels. While often associated with hot flashes and mood fluctuations, this period also ushers in a less discussed, yet highly prevalent, set of physical changes impacting joints and connective tissues. Researchers are increasingly recognizing and defining this experience as the "musculoskeletal syndrome of menopause," a term that encapsulates the widespread joint stiffness, pain, and altered sensation women may encounter in their knees, hips, and hands. A comprehensive 2024 review published in the journal Climacteric by researchers from the University of Central Florida College of Medicine and Duke University School of Medicine underscores the significance of this syndrome, estimating that over 70% of women navigating menopause will experience these musculoskeletal shifts. Understanding the underlying mechanisms and proactive strategies can empower women to manage these changes effectively and maintain an active lifestyle.
The Crucial Role of Cartilage During Menopause
At the heart of these menopausal musculoskeletal changes lies cartilage, the resilient connective tissue that cushions joints and facilitates smooth movement. Unlike many other tissues in the body, cartilage lacks its own direct blood supply, making its maintenance and repair a delicate process. It relies on a specialized population of cells known as chondrocytes, which are responsible for synthesizing and preserving the structural integrity of this vital tissue. Estrogen plays a critical role in supporting chondrocyte function, aiding them in producing essential components like collagen and proteoglycans, the building blocks of healthy cartilage. This crucial support mechanism is detailed in a 2025 review in npj Women’s Health. As estrogen levels naturally decrease during menopause, chondrocytes receive diminished support, potentially compromising their ability to effectively maintain and repair cartilage. This hormonal shift can lead to a gradual degradation of cartilage, manifesting as increased friction, inflammation, and the characteristic aches and stiffness associated with the musculoskeletal syndrome of menopause.
A Holistic Approach: Movement, Sleep, Nutrition, and Targeted Supplementation
Fortunately, the body possesses remarkable adaptive capabilities, and a combination of daily habits can provide substantial support to cartilage health throughout the menopausal transition. These pillars of support include regular movement, quality sleep, a nutrient-rich diet, and, in some cases, targeted supplementation.
The Power of Movement: Physical activity is not merely about cardiovascular health or muscle strength; it plays a direct and vital role in the well-being of joint cartilage. A small but insightful 2024 imaging study utilized MRI to observe knee cartilage in eight healthy adults as they transitioned between standing, walking, and lying down. The findings provided compelling evidence that joint activity significantly enhances cartilage recovery. Specifically, the study revealed that cartilage recovered from compression nearly three times faster during walking compared to periods of inactivity while lying still. This research offers the first direct scientific demonstration that the mechanical loading and unloading cycles inherent in everyday activities like walking actively promote the recovery of cartilage from the stresses it endures. Engaging in regular, low-impact exercises can therefore help maintain cartilage resilience and function.
The Restorative Benefits of Sleep: Sleep is a fundamental biological process essential for numerous bodily functions, including tissue repair and growth. During sleep, the body releases growth hormone, a key anabolic hormone crucial for building and repairing muscle and bone. A groundbreaking 2025 study published in the journal Cell, led by researchers at UC Berkeley, has shed new light on the intricate neural circuitry within the brain that governs the release of growth hormone during both REM and non-REM sleep stages. While the general benefit of sleep for growth hormone production was long understood, the precise neural mechanisms remained elusive until this research. Consistent, high-quality sleep is therefore paramount for optimizing the body’s natural regenerative processes, including those vital for cartilage health.
Nourishing Your Joints Through Diet: The foods we consume play a significant role in modulating inflammatory processes and providing essential nutrients for tissue repair. A 2026 review in Nutrients highlights the beneficial effects of certain dietary components on cartilage health. Polyphenols, abundant in fruits, vegetables, and olive oil, along with curcumin (found in turmeric) and omega-3 fatty acids derived from fatty fish, have been shown to help regulate the signaling pathways that can lead to the breakdown of cartilage’s structural proteins. It is important to note that this nutritional evidence, while promising, primarily stems from laboratory and animal studies. The review emphasizes that nutrition should be viewed as a complementary approach to established strategies like exercise, rather than a replacement. Furthermore, the authors caution that the efficacy of commercially available botanical supplements can vary significantly due to differences in standardization, absorption enhancers, and particle size, making it challenging to extrapolate findings from one product to another.
Navigating Structural Supplementation for Cartilage Health
While movement, sleep, and nutrition form the foundational pillars of joint support, targeted supplementation can offer an additional layer of assistance, particularly for women experiencing significant musculoskeletal changes during menopause. The landscape of joint supplements has evolved considerably, with a shift towards products backed by rigorous clinical evidence.
For decades, glucosamine and chondroitin were the go-to supplements for joint health. However, extensive meta-analyses of research on these compounds have consistently yielded modest or negligible benefits compared to placebo for improving joint comfort or function. This lack of robust evidence has led many clinicians to re-evaluate their recommendations.
Tom Bayne, DC, an educator with Calroy Health Sciences, reflects on this shift: "I recommended glucosamine and chondroitin to patients for years. It was the standard of care, and there wasn’t much else to point to. The honest answer when patients asked if it would work was ‘maybe.’ What’s different now is that we have published research, including a placebo-controlled study, with measurable outcomes on a new supplement. That gives clinicians and patients confidence."
This evolving understanding points towards the importance of formulation-specific research. A truly effective supplement should be studied as a finished product, administered at the intended dosage and in the form it is sold. Calroy Health Sciences’ joint and cartilage formula, Cartigenix HP® with RestorCel®, exemplifies this evidence-based approach. This formula, a standardized blend of Boswellia serrata and celery seed extract, has undergone extensive evaluation in multiple human studies. These include a prospective study of 1,236 participants (Desai, 2022), an observational study of 394 individuals (Desai, 2024), and a pivotal randomized, double-blind, placebo-controlled trial involving 62 participants (Vaidya, 2025). Collectively, these studies involve over 1,600 participants, providing a robust foundation of evidence.
Insights from the Placebo-Controlled Trial
The 2025 Vaidya trial, a randomized, double-blind, placebo-controlled study, offered particularly compelling insights into the efficacy of Cartigenix HP®. In this trial, participants taking the formula experienced a significant 64% reduction in WOMAC pain scores over a 90-day period. Moreover, participants reported noticeable improvements in their joint discomfort as early as 15 days into the study.
Beyond subjective reports of pain relief, the trial also investigated objective measures of cartilage health by tracking specific blood biomarkers. Participants receiving the Cartigenix HP® formula demonstrated significant increases in PIIANP and PIICP, validated markers that reflect the body’s production of type II procollagen. Type II procollagen is a fundamental building block of the cartilage matrix, and these elevated levels indicate active synthesis of new cartilage. Conversely, the trial recorded significant decreases in CTX-II and COMP, biomarkers associated with cartilage degeneration. Functional improvements were also observed, with participants showing a 50% improvement in walking distance on the six-minute walk test over the same 90-day period.
The trial enrolled 62 men and women aged 40 to 65 who had pre-existing knee discomfort. This age range is particularly relevant as it encompasses the menopausal transition for women. For these women, the observed increases in collagen markers align with the physiological processes that estrogen normally helps to sustain in cartilage.
Conclusion: Embracing Proactive Joint Health
As women enter and progress through menopause, the natural decline in estrogen levels can diminish the crucial support chondrocytes require for building and maintaining cartilage. This often leads to palpable changes in the knees, hips, and hands, contributing to the musculoskeletal syndrome of menopause. However, emerging research and a deeper understanding of physiological processes offer promising avenues for support. By integrating regular movement, prioritizing consistent, quality sleep, adopting a nutrient-dense diet, and considering targeted, evidence-based supplementation, women can proactively support their cartilage health and maintain joint comfort and function throughout this significant life stage.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
*As shown in a placebo-controlled, randomized, controlled human research study (Vaidya 2025) and an observational study (Desai 2024). A prospective study (n=1,236) similarly demonstrated significant improvements in pain scores, along with quality of life measures (Desai 2022).
Frequently Asked Questions
Question: When do menopause-related joint changes typically begin?
Answer: Many women notice changes in their knees, hips, or hands beginning around their mid-40s through their 50s as they enter and move through the menopause transition. A 2024 review in Climacteric estimates that more than 70% of women in the transition experience musculoskeletal changes, a pattern researchers now call the musculoskeletal syndrome of menopause.
Question: What supports cartilage during menopause?
Answer: Estrogen helps chondrocytes, the cells that maintain cartilage, produce the collagen and proteoglycans that make up the tissue. As estrogen falls during menopause, daily habits add support. Walking helps cartilage recover from everyday loading, consistent sleep supports overnight growth hormone release, and polyphenols from produce and olive oil, along with omega-3s from fish, support cartilage’s structural proteins.
Question: Do glucosamine and chondroitin work for joint changes in midlife?
Answer: Glucosamine and chondroitin have been studied for decades, and the research reports small or no average difference compared with placebo for joint comfort or function.
Question: What should a woman over 50 look for in a cartilage supplement?
Answer: Look for a formula tested in human studies at the dose and in the form sold. A placebo-controlled trial shows whether results come from the product itself, informing buyers and their providers to see what the research measured.
Question: What are cartilage biomarkers?
Answer: Cartilage biomarkers are blood measures researchers use to track activity in cartilage. PIIANP and PIICP reflect production of type II procollagen, the building block of cartilage matrix. CTX-II and COMP reflect cartilage breakdown. These markers are research tools used in clinical studies, separate from the lab tests a clinician orders in routine care.
